CA2306379A1 - Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye - Google Patents

Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye Download PDF

Info

Publication number
CA2306379A1
CA2306379A1 CA002306379A CA2306379A CA2306379A1 CA 2306379 A1 CA2306379 A1 CA 2306379A1 CA 002306379 A CA002306379 A CA 002306379A CA 2306379 A CA2306379 A CA 2306379A CA 2306379 A1 CA2306379 A1 CA 2306379A1
Authority
CA
Canada
Prior art keywords
glycosaminoglycans
treatment
pharmaceutical preparations
sulfate
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002306379A
Other languages
English (en)
French (fr)
Inventor
Fokko Van Der Woude
Dieter Herr
Volker Laux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2306379A1 publication Critical patent/CA2306379A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA002306379A 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye Abandoned CA2306379A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19747195A DE19747195A1 (de) 1997-10-24 1997-10-24 Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
DE19747195.1 1997-10-24
PCT/EP1998/006703 WO1999021538A2 (de) 1997-10-24 1998-10-22 Verwendung von glykosaminoglykanen zur herstellung von pharmazeutischen zubereitungen zur behandlung von mit diabetes assoziierten augenkrankheiten

Publications (1)

Publication Number Publication Date
CA2306379A1 true CA2306379A1 (en) 1999-05-06

Family

ID=7846613

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002306379A Abandoned CA2306379A1 (en) 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye

Country Status (13)

Country Link
EP (1) EP1047434A2 (ko)
JP (1) JP2001520987A (ko)
KR (1) KR20010024550A (ko)
CN (1) CN1277554A (ko)
AU (1) AU749673B2 (ko)
BR (1) BR9813098A (ko)
CA (1) CA2306379A1 (ko)
DE (1) DE19747195A1 (ko)
HU (1) HUP0004647A3 (ko)
IL (1) IL135171A0 (ko)
NO (1) NO20001895D0 (ko)
WO (1) WO1999021538A2 (ko)
ZA (1) ZA989665B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
CN101584704B (zh) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 肝素、低分子肝素可药用盐或其衍生物的医药用途
JPWO2011122321A1 (ja) * 2010-03-29 2013-07-08 国立大学法人名古屋大学 ヘパリン結合性蛋白に対する生理活性阻害剤
CN107137421A (zh) * 2017-05-25 2017-09-08 青岛市中心医院 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597484B1 (fr) * 1986-04-17 1988-12-23 Sanofi Sa Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
DE3875349D1 (de) * 1988-06-27 1992-11-19 Roland Reiner Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
PT93847A (pt) * 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
AU7520394A (en) * 1993-08-13 1995-03-14 Glycomed Incorporated Bridged oligosaccharides and sulfated derivatives thereof
EP0722326A4 (en) * 1993-10-07 1999-10-06 Glycomed Inc HIGHLY SULFATED MALTOOLIGOSSACCHARIDES WITH HEPARIN-LIKE PROPERTIES
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
AU9160498A (en) * 1997-07-28 1999-02-16 Rijksuniversiteit Leiden Use of sulfated glycosaminoglycans for treating of retinopathy

Also Published As

Publication number Publication date
NO20001895L (no) 2000-04-12
ZA989665B (en) 2000-04-25
HUP0004647A3 (en) 2002-01-28
WO1999021538A3 (de) 1999-08-05
WO1999021538A2 (de) 1999-05-06
CN1277554A (zh) 2000-12-20
EP1047434A2 (de) 2000-11-02
HUP0004647A2 (hu) 2001-05-28
AU1335599A (en) 1999-05-17
DE19747195A1 (de) 1999-04-29
KR20010024550A (ko) 2001-03-26
BR9813098A (pt) 2000-08-15
JP2001520987A (ja) 2001-11-06
IL135171A0 (en) 2001-05-20
NO20001895D0 (no) 2000-04-12
AU749673B2 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
Parving et al. Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
CA2449962A1 (en) Use of glycosaminoglycans for the treatment of hiv-associated nephropathy
CN110420315A (zh) 枸杞糖肽在制备治疗三高药物中的应用
FR2541115A1 (fr) Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses
EP0809505B1 (en) Use of pentosan polysulfate for the resolution of scars in chronic progressive vascular diseases
CN112316150B (zh) 一种用于预防或治疗代谢或损伤相关疾病的药物组合物
AU749673B2 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
CN1921853A (zh) 重度糖尿病性视网膜病的预防或治疗剂
NZ500527A (en) Use of pentosan polysulfate (PPS) for treating chronic progressive vascular scarring diseases
TW202038937A (zh) 治療高血壓的方法
RU2679602C1 (ru) Состав для лечения сахарного диабета
AU755534B2 (en) Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy
SK92194A3 (en) Pharmaceutical agent method of its preparing and using
MXPA00003598A (es) El uso de glicosaminoglicanos para producir preparaciones farmaceuticas para tratar desordenes en los ojos asociados con diabetes
US20040132635A1 (en) Method for prevention and treatment of kidney diseases
CZ20001455A3 (cs) Použití glykosaminoglykanů pro přípravu farmaceutických přípravků pro léčení očních poruch spojených s diabetem
Akarsu Hydroxychloroquine: From Pharmacological Profile to Neglected Adverse Reactions
JPH08165243A (ja) 抗炎症剤
JP4925406B2 (ja) 糖尿病性腎症の予防及び／又は治療剤
RU2362554C2 (ru) Регенерирующее противовоспалительное средство и способы лечения с помощью этого средства
EP3466433B1 (en) Triacetyl-3-hydroxyl phenyl adenosine for use in treating acute vascular inflammations
JP2875541B2 (ja) 血行再建術後の再閉塞防止剤
RU2195297C2 (ru) Способ лечения дистрофических заболеваний глаз
Tkachenko et al. Kidney damage in patients with rheumatoid arthritis
RU2095067C1 (ru) Способ стимуляции репаративных и трофических процессов в тканях организма

Legal Events

Date Code Title Description
FZDE Discontinued